Report Detail
Global Acute Myeloid Leukemia Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030
- RnM4600251 |
- 02 July, 2024 |
- Global |
- 91 Pages |
- GIR (Global Info Research) |
- Other
According to our (Global Info Research) latest study, the global Acute Myeloid Leukemia Treatment market size was valued at USD 608.8 million in 2023 and is forecast to a readjusted size of USD 1014.1 million by 2030 with a CAGR of 7.6% during review period.
Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from birth to 19 years of age diagnosed with leukemia have acute myeloid leukemia. The risk of acute myeloid leukemia is closely associated with age. About 90% of acute myeloid leukemia is diagnosed in middle age.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Acute Myeloid Leukemia Treatment industry chain, the market status of Hospital (DC Regimen, AVD Regimen), Clinic (DC Regimen, AVD Regimen), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Acute Myeloid Leukemia Treatment.
Regionally, the report analyzes the Acute Myeloid Leukemia Treatment markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Acute Myeloid Leukemia Treatment market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Acute Myeloid Leukemia Treatment market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Acute Myeloid Leukemia Treatment industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., DC Regimen, AVD Regimen).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Acute Myeloid Leukemia Treatment market.
Regional Analysis: The report involves examining the Acute Myeloid Leukemia Treatment market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Acute Myeloid Leukemia Treatment market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Acute Myeloid Leukemia Treatment:
Company Analysis: Report covers individual Acute Myeloid Leukemia Treatment players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Acute Myeloid Leukemia Treatment This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).
Technology Analysis: Report covers specific technologies relevant to Acute Myeloid Leukemia Treatment. It assesses the current state, advancements, and potential future developments in Acute Myeloid Leukemia Treatment areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Acute Myeloid Leukemia Treatment market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Acute Myeloid Leukemia Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
DC Regimen
AVD Regimen
VCD Regimen
Market segment by Application
Hospital
Clinic
Others
Market segment by players, this report covers
Ambit Biosciences Corporation
Celgene Corporation
Cephalon
Clavis Pharma
Eisai
Genzyme Corporation
Sunesis Pharmaceuticals
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Acute Myeloid Leukemia Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Acute Myeloid Leukemia Treatment, with revenue, gross margin and global market share of Acute Myeloid Leukemia Treatment from 2019 to 2024.
Chapter 3, the Acute Myeloid Leukemia Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Acute Myeloid Leukemia Treatment market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Acute Myeloid Leukemia Treatment.
Chapter 13, to describe Acute Myeloid Leukemia Treatment research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Acute Myeloid Leukemia Treatment
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Acute Myeloid Leukemia Treatment by Type
- 1.3.1 Overview: Global Acute Myeloid Leukemia Treatment Market Size by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 Global Acute Myeloid Leukemia Treatment Consumption Value Market Share by Type in 2023
- 1.3.3 DC Regimen
- 1.3.4 AVD Regimen
- 1.3.5 VCD Regimen
- 1.4 Global Acute Myeloid Leukemia Treatment Market by Application
- 1.4.1 Overview: Global Acute Myeloid Leukemia Treatment Market Size by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Hospital
- 1.4.3 Clinic
- 1.4.4 Others
- 1.5 Global Acute Myeloid Leukemia Treatment Market Size & Forecast
- 1.6 Global Acute Myeloid Leukemia Treatment Market Size and Forecast by Region
- 1.6.1 Global Acute Myeloid Leukemia Treatment Market Size by Region: 2019 VS 2023 VS 2030
- 1.6.2 Global Acute Myeloid Leukemia Treatment Market Size by Region, (2019-2030)
- 1.6.3 North America Acute Myeloid Leukemia Treatment Market Size and Prospect (2019-2030)
- 1.6.4 Europe Acute Myeloid Leukemia Treatment Market Size and Prospect (2019-2030)
- 1.6.5 Asia-Pacific Acute Myeloid Leukemia Treatment Market Size and Prospect (2019-2030)
- 1.6.6 South America Acute Myeloid Leukemia Treatment Market Size and Prospect (2019-2030)
- 1.6.7 Middle East and Africa Acute Myeloid Leukemia Treatment Market Size and Prospect (2019-2030)
2 Company Profiles
- 2.1 Ambit Biosciences Corporation
- 2.1.1 Ambit Biosciences Corporation Details
- 2.1.2 Ambit Biosciences Corporation Major Business
- 2.1.3 Ambit Biosciences Corporation Acute Myeloid Leukemia Treatment Product and Solutions
- 2.1.4 Ambit Biosciences Corporation Acute Myeloid Leukemia Treatment Revenue, Gross Margin and Market Share (2019-2024)
- 2.1.5 Ambit Biosciences Corporation Recent Developments and Future Plans
- 2.2 Celgene Corporation
- 2.2.1 Celgene Corporation Details
- 2.2.2 Celgene Corporation Major Business
- 2.2.3 Celgene Corporation Acute Myeloid Leukemia Treatment Product and Solutions
- 2.2.4 Celgene Corporation Acute Myeloid Leukemia Treatment Revenue, Gross Margin and Market Share (2019-2024)
- 2.2.5 Celgene Corporation Recent Developments and Future Plans
- 2.3 Cephalon
- 2.3.1 Cephalon Details
- 2.3.2 Cephalon Major Business
- 2.3.3 Cephalon Acute Myeloid Leukemia Treatment Product and Solutions
- 2.3.4 Cephalon Acute Myeloid Leukemia Treatment Revenue, Gross Margin and Market Share (2019-2024)
- 2.3.5 Cephalon Recent Developments and Future Plans
- 2.4 Clavis Pharma
- 2.4.1 Clavis Pharma Details
- 2.4.2 Clavis Pharma Major Business
- 2.4.3 Clavis Pharma Acute Myeloid Leukemia Treatment Product and Solutions
- 2.4.4 Clavis Pharma Acute Myeloid Leukemia Treatment Revenue, Gross Margin and Market Share (2019-2024)
- 2.4.5 Clavis Pharma Recent Developments and Future Plans
- 2.5 Eisai
- 2.5.1 Eisai Details
- 2.5.2 Eisai Major Business
- 2.5.3 Eisai Acute Myeloid Leukemia Treatment Product and Solutions
- 2.5.4 Eisai Acute Myeloid Leukemia Treatment Revenue, Gross Margin and Market Share (2019-2024)
- 2.5.5 Eisai Recent Developments and Future Plans
- 2.6 Genzyme Corporation
- 2.6.1 Genzyme Corporation Details
- 2.6.2 Genzyme Corporation Major Business
- 2.6.3 Genzyme Corporation Acute Myeloid Leukemia Treatment Product and Solutions
- 2.6.4 Genzyme Corporation Acute Myeloid Leukemia Treatment Revenue, Gross Margin and Market Share (2019-2024)
- 2.6.5 Genzyme Corporation Recent Developments and Future Plans
- 2.7 Sunesis Pharmaceuticals
- 2.7.1 Sunesis Pharmaceuticals Details
- 2.7.2 Sunesis Pharmaceuticals Major Business
- 2.7.3 Sunesis Pharmaceuticals Acute Myeloid Leukemia Treatment Product and Solutions
- 2.7.4 Sunesis Pharmaceuticals Acute Myeloid Leukemia Treatment Revenue, Gross Margin and Market Share (2019-2024)
- 2.7.5 Sunesis Pharmaceuticals Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Acute Myeloid Leukemia Treatment Revenue and Share by Players (2019-2024)
- 3.2 Market Share Analysis (2023)
- 3.2.1 Market Share of Acute Myeloid Leukemia Treatment by Company Revenue
- 3.2.2 Top 3 Acute Myeloid Leukemia Treatment Players Market Share in 2023
- 3.2.3 Top 6 Acute Myeloid Leukemia Treatment Players Market Share in 2023
- 3.3 Acute Myeloid Leukemia Treatment Market: Overall Company Footprint Analysis
- 3.3.1 Acute Myeloid Leukemia Treatment Market: Region Footprint
- 3.3.2 Acute Myeloid Leukemia Treatment Market: Company Product Type Footprint
- 3.3.3 Acute Myeloid Leukemia Treatment Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Acute Myeloid Leukemia Treatment Consumption Value and Market Share by Type (2019-2024)
- 4.2 Global Acute Myeloid Leukemia Treatment Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
- 5.1 Global Acute Myeloid Leukemia Treatment Consumption Value Market Share by Application (2019-2024)
- 5.2 Global Acute Myeloid Leukemia Treatment Market Forecast by Application (2025-2030)
6 North America
- 6.1 North America Acute Myeloid Leukemia Treatment Consumption Value by Type (2019-2030)
- 6.2 North America Acute Myeloid Leukemia Treatment Consumption Value by Application (2019-2030)
- 6.3 North America Acute Myeloid Leukemia Treatment Market Size by Country
- 6.3.1 North America Acute Myeloid Leukemia Treatment Consumption Value by Country (2019-2030)
- 6.3.2 United States Acute Myeloid Leukemia Treatment Market Size and Forecast (2019-2030)
- 6.3.3 Canada Acute Myeloid Leukemia Treatment Market Size and Forecast (2019-2030)
- 6.3.4 Mexico Acute Myeloid Leukemia Treatment Market Size and Forecast (2019-2030)
7 Europe
- 7.1 Europe Acute Myeloid Leukemia Treatment Consumption Value by Type (2019-2030)
- 7.2 Europe Acute Myeloid Leukemia Treatment Consumption Value by Application (2019-2030)
- 7.3 Europe Acute Myeloid Leukemia Treatment Market Size by Country
- 7.3.1 Europe Acute Myeloid Leukemia Treatment Consumption Value by Country (2019-2030)
- 7.3.2 Germany Acute Myeloid Leukemia Treatment Market Size and Forecast (2019-2030)
- 7.3.3 France Acute Myeloid Leukemia Treatment Market Size and Forecast (2019-2030)
- 7.3.4 United Kingdom Acute Myeloid Leukemia Treatment Market Size and Forecast (2019-2030)
- 7.3.5 Russia Acute Myeloid Leukemia Treatment Market Size and Forecast (2019-2030)
- 7.3.6 Italy Acute Myeloid Leukemia Treatment Market Size and Forecast (2019-2030)
8 Asia-Pacific
- 8.1 Asia-Pacific Acute Myeloid Leukemia Treatment Consumption Value by Type (2019-2030)
- 8.2 Asia-Pacific Acute Myeloid Leukemia Treatment Consumption Value by Application (2019-2030)
- 8.3 Asia-Pacific Acute Myeloid Leukemia Treatment Market Size by Region
- 8.3.1 Asia-Pacific Acute Myeloid Leukemia Treatment Consumption Value by Region (2019-2030)
- 8.3.2 China Acute Myeloid Leukemia Treatment Market Size and Forecast (2019-2030)
- 8.3.3 Japan Acute Myeloid Leukemia Treatment Market Size and Forecast (2019-2030)
- 8.3.4 South Korea Acute Myeloid Leukemia Treatment Market Size and Forecast (2019-2030)
- 8.3.5 India Acute Myeloid Leukemia Treatment Market Size and Forecast (2019-2030)
- 8.3.6 Southeast Asia Acute Myeloid Leukemia Treatment Market Size and Forecast (2019-2030)
- 8.3.7 Australia Acute Myeloid Leukemia Treatment Market Size and Forecast (2019-2030)
9 South America
- 9.1 South America Acute Myeloid Leukemia Treatment Consumption Value by Type (2019-2030)
- 9.2 South America Acute Myeloid Leukemia Treatment Consumption Value by Application (2019-2030)
- 9.3 South America Acute Myeloid Leukemia Treatment Market Size by Country
- 9.3.1 South America Acute Myeloid Leukemia Treatment Consumption Value by Country (2019-2030)
- 9.3.2 Brazil Acute Myeloid Leukemia Treatment Market Size and Forecast (2019-2030)
- 9.3.3 Argentina Acute Myeloid Leukemia Treatment Market Size and Forecast (2019-2030)
10 Middle East & Africa
- 10.1 Middle East & Africa Acute Myeloid Leukemia Treatment Consumption Value by Type (2019-2030)
- 10.2 Middle East & Africa Acute Myeloid Leukemia Treatment Consumption Value by Application (2019-2030)
- 10.3 Middle East & Africa Acute Myeloid Leukemia Treatment Market Size by Country
- 10.3.1 Middle East & Africa Acute Myeloid Leukemia Treatment Consumption Value by Country (2019-2030)
- 10.3.2 Turkey Acute Myeloid Leukemia Treatment Market Size and Forecast (2019-2030)
- 10.3.3 Saudi Arabia Acute Myeloid Leukemia Treatment Market Size and Forecast (2019-2030)
- 10.3.4 UAE Acute Myeloid Leukemia Treatment Market Size and Forecast (2019-2030)
11 Market Dynamics
- 11.1 Acute Myeloid Leukemia Treatment Market Drivers
- 11.2 Acute Myeloid Leukemia Treatment Market Restraints
- 11.3 Acute Myeloid Leukemia Treatment Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Acute Myeloid Leukemia Treatment Industry Chain
- 12.2 Acute Myeloid Leukemia Treatment Upstream Analysis
- 12.3 Acute Myeloid Leukemia Treatment Midstream Analysis
- 12.4 Acute Myeloid Leukemia Treatment Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Acute Myeloid Leukemia Treatment. Industry analysis & Market Report on Acute Myeloid Leukemia Treatment is a syndicated market report, published as Global Acute Myeloid Leukemia Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Acute Myeloid Leukemia Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
